CD8+ T-cell | IL-2 | % TCRγδ+ | UBE2L3 | |
---|---|---|---|---|
Patient requirements | ||||
Strict GFD | Yes | Yes | No | Yes |
GC requirement | Yes | Yes | No | No |
GC duration | 3 days | 1 day | – | – |
Intervention | Minimally invasive (blood) | Minimally invasive (blood) | Invasive (upper endoscopy, biopsy) | Minimally invasive (blood) |
Procedure delay | Minimal | Minimal | Endoscopy waiting list | Minimal |
Visits for sample collection | 2 (baseline and day 6) | 2 (baseline and 4 h) | 1 | 1 |
Technical requirements | ||||
Processing time/sample | 2.5 h | 9 h | 3 h | 6 h |
Special requirement | Flow cytometer | Ultrasensitive immunoassay platform | Flow cytometer | Real-time PCR |
Minimal sample size for cost-effectiveness | 1 patient | 10 patients | 1 patient | 1 patienta |
Time to diagnostic results | 6 days | 2 daysb | 1 day | 1–2 daysb |